Weiss Multi-Strategy Advisers’s Cymabay Therapeutics CBAY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-65,000	Closed	-$333K	–	757
2019 Q3	$333K	Hold	65,000	–	–	0.01%	515
2019 Q2	$465K	Sell	65,000 -15,000	-19%	-$170K	0.01%	427
2019 Q1	$1.06M	Buy	80,000 +18,000	+29%	+$191K	0.03%	387
2018 Q4	$488K	Buy	62,000 +6,936	+13%	+$66K	0.02%	350
2018 Q3	$610K	Buy	55,064 +241	+0.4%	+$2.99K	0.02%	428
2018 Q2	$736K	Buy	54,823 +13,823	+34%	+$173K	0.02%	467
2018 Q1	$533K	Buy	41,000 +16,000	+64%	+$199K	0.02%	460
2017 Q4	$230K	Buy	+25,000	New	+$214K	0.01%	529

Other funds holding CBAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CBAY Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Cymabay Therapeutics (CBAY) in Q4 2019, closing a stake of 65,000 shares — an estimated $333K sold.

Weiss Multi-Strategy Advisers first reported a position in CBAY in Q4 2017 and held it in 8 quarters. The position peaked at $1.06M in Q1 2019. 113 funds tracked by Wall St. Rank hold CBAY as of Q4 2019.

Weiss Multi-Strategy Advisers reported no remaining Cymabay Therapeutics position as of Q4 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 65,000 Cymabay Therapeutics shares in Q4 2019, an estimated $333K.
Weiss Multi-Strategy Advisers first reported a position in Cymabay Therapeutics in Q4 2017 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Cymabay Therapeutics position peaked at $1.06M in Q1 2019.
113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.